New members receive 100,000 Gold Coins and 50 free Sweeps Coins with a first purchase of $9.99, unlocking access to over 20 live dealer tables.

Before becoming a Vietnamese representative participating in the International Artificial Intelligence Olympiad, Kỳ Nam had ...

Misleading weather app icons are affecting major attractions like zoos. Rain icons on apps can imply all-day rain, impacting visitor numbers. Weather apps are valuable for current conditions like ...

The AIM All-Share is down 2.6 per cent this week and off around 7 per cent since the US and Israel began bombing Iran.

The justification for Yerevan's refusal to agree to the next batch of humanitarian aid from Russia for those displaced from Nagorno-Karabakh raises more questions than answers. Russian Ministry of ...

With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...

Rust-based VENON malware targets 33 Brazilian financial platforms using advanced evasion and overlays, enabling credential theft.

Saga Communications, Inc. (Nasdaq - SGA) (the “Company” or “Saga”) today reported that net revenue decreased 9.3% to $26.5 million for the quarter ended December 31, 2025 compared to $29.2 million for ...

Sweepstakes casinos are different from other online casinos because players do not use real money. Gold Coins are used for socializing only, and Sweeps Coins are used to win real prizes after ...

Aptera Motors CEO Chris Anthony explains the company's revamped approach to car maintenance, including QR code diagnostics, modular parts, right-to-repair access, and mobile service vans.

High Courts held that undervaluation disputes must be examined through assessment proceedings under Sections 73 or 74. Detention during transit is not justified if proper documents accompany the ...

Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) announced today that it has initiated a Phase I clinical trial of ME3241 ...